JENNIFER SCHMIDT: Open Payments
NPI 1982676540 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 51 payments from 15 companies in 2025. Trend: 2023 $541 · 2024 $863 · 2025 $980
Food & beverage: $981
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $308 |
| Lilly USA, LLC | 9 | $189 |
| ABBVIE INC. | 10 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Amgen Inc. | 3 | $47 |
| Abbott Laboratories | 2 | $39 |
| Eisai Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
Products named: Wegovy, MOUNJARO, VRAYLAR, UBRELVY, AIRSUPRA, ZEPBOUND, KISUNLA, Leqembi.
Industry payments across NC — which companies pay providers there.
